Frank Neumann
Corporate Officer/Principal bij KITE PHARMA INC
Actieve functies van Frank Neumann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01-01-2021 | - |
Loopbaan van Frank Neumann
Eerdere bekende functies van Frank Neumann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VERASTEM, INC. | Hoofd Techniek/Wetenschap/O&O | 06-01-2021 | 20-01-2021 |
| BLUEBIRD BIO, INC. | Corporate Officer/Principal | - | - |
Opleiding van Frank Neumann
| Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
| University of Bonn | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Duitsland | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VERASTEM, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Beurs
- Insiders
- Frank Neumann
- Ervaring